Cell surface staining of MHC-I expression on tumor cells indicated that overexpression of Ezh2, but not Ezh2 F667I or ΔSET mutant, in Usp22-null cells impaired MHC-I expression (Figure 4L and Supplemental Figure 9C). The gene discussed is USP22; the disease is neoplasm.